Cerevel Therapeutics
CERE
$40.74
Share price
0.25%
Change (1 day)
24.97%
Change (1 year)
Categories
Cerevel Therapeutics (CERE) - Total debt
Total debt on the balance sheet as of March 2024 : $0.36 B
According to Cerevel Therapeutics's latest financial reports the company's total debt is $0.36 B. A company’s total debt is the sum of all current and non-current debts.
Cerevel Therapeutics - Total debt on balance sheet (from 2020 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $0.36 B | -0.26% |
| 2022-12-31 | $0.36 B | 911.22% |
| 2021-12-31 | $36.54 M | 10.73% |
| 2020-12-31 | $33 M | 16.17% |
| 2019-12-31 | $28.41 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Archer Daniels Midland (ADM)
ADM | $11.28 B | 2,964.88% | 🇺🇸 USA |
 Campbell Soup CPB | $4.52 B | 1,127.26% | 🇺🇸 USA |
 Dow DOW | $17.73 B | 4,716.17% | 🇺🇸 USA |
 Dupont De Nemours DD | $7.69 B | 1,988.51% | 🇺🇸 USA |